Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Payables: 2022-2024

Historic Payables for Abivax (ABVX) over the last 3 years, with Dec 2024 value amounting to $46.8 million.

  • Abivax's Payables rose 90.10% to $65.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $205.6 million, marking a year-over-year change of. This contributed to the annual value of $46.8 million for FY2024, which is 7.83% down from last year.
  • Abivax's Payables amounted to $46.8 million in FY2024, which was down 7.83% from $50.8 million recorded in FY2023.
  • In the past 5 years, Abivax's Payables registered a high of $50.8 million during FY2023, and its lowest value of $16.3 million during FY2022.
  • Moreover, its 3-year median value for Payables was $46.8 million (2024), whereas its average is $38.0 million.
  • Its Payables has fluctuated over the past 5 years, first surged by 211.51% in 2023, then dropped by 7.83% in 2024.
  • Yearly analysis of 3 years shows Abivax's Payables stood at $16.3 million in 2022, then spiked by 211.51% to $50.8 million in 2023, then dropped by 7.83% to $46.8 million in 2024.